Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that does not express the estrogen receptor (ER), epidermal growth factor receptor 2 (HER2) or progesterone receptor (PR). This evidence concerns the gene ESR1 and breast cancer.